A quick take on Netflix and Peloton, Siemens Gamesa’s inflation scare A quick take on Netflix and Peloton, Siemens Gamesa’s inflation scare A quick take on Netflix and Peloton, Siemens Gamesa’s inflation scare

A quick take on Netflix and Peloton, Siemens Gamesa’s inflation scare

Equities 6 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  Netflix disappointed investors yesterday with a fiscal outlook for operating margin that was 3-4%-points below consensus and the punishment was harsh with the stock down 20% in extended trading. It highlights how important it is for companies to meet profit expectations now that interest rates are on the rise. Peloton, another pandemic darling, came out yesterday with the announcement that it is delaying a factory opening and considering laying off employees in a sign that demand is coming off. Finally we take a look at Siemens Gamesa which is getting hit hard by inflation and logistical issues, and highlights the most important earnings releases next week including Microsoft, Tesla, and Apple.

Pandemic darlings under pressure

Netflix and Peloton were among the big losers in yesterday’s session. They were the pandemic darlings, but reopening headwinds have hit both companies on top line growth. Netflix shares were down 20% in extended trading on Q4 earnings on a weak outlook. Q4 EPS was $1.33 vs est. $0.81 and revenue in line with estimates, but the outlook was disappointing with net subscriber additions in Q1 guided at 2.5mn vs est. 6.3mn and EPS of $2.86 vs est. $3.37. But the most disappointing against consensus was the fiscal year operating margin target of 19-20% vs 23% expected. The market reaction is a replay of DocuSign in December where investors are punishing companies that cannot meet operating margin expectations. The narrative will short-term focus on lack of subscriber growth so Netflix should begin focusing less on user metrics and more on free cash flows going forward.

Source: Saxo Group

Peloton was a pandemic darling as people favoured their tread bikes to exercise during the lockdown in the US. But as society has reopened sales growth has stalled and yesterday’s preliminary Q2 figures (ending 31 Dec), showed revenue in line with estimates but is delaying an opening of a $400mn factory which was expected to meet demand and the delay and management talks about layoffs can only be viewed as signs that demand is coming off rapidly.

Siemens Gamesa shows how real inflation is

The world’s largest manufacturer of offshore wind turbines published FY22 Q1 (ending 31 Dec) earlier this morning which was grim reading for investors. Underlying operating profit was negative €309mn and the fiscal year guidance is now -4% to +1% on underlying EBIT margin which significantly below where consensus was looking for €206mn in EBIT which is an EBIT margin of a little more than 2%. The problems for the industry has persisted for more than a year which includes difficulties sourcing components, factory delays due to Covid-19, logistics nightmare, and generally rising input costs such as rising steel prices. Wind turbine manufacturers are raising prices to offset rising input costs but it has the negative consequence of reducing order intake creating a double whammy for investors. While the green transformation will continue to ensure high long-term growth for this industry the narrative is clearly negative in the short-term.

Earnings season shifts gear next week

Next week 177 companies report earnings out the around 2,500 companies we track during the earnings season. The list below shows the most important earnings releases measured against interesting themes to watch and those that can either move the overall market or an industry. The three most important earnings releases are from Microsoft (Tuesday), Tesla (Wednesday), and Apple (Thursday).

Monday: IBM, Philips, Halliburton

Tuesday: Coloplast, Atlas Copco, Ericsson, Microsoft, Johnson & Johnson, NextEra Energy, Texas Instruments, American Express, General Electric, 3M, Moderna,

Wednesday: Christian Dior, Nidec, FANUC, Lonza Group, Tesla, Abbott Laboratories, Intel, Boeing, Freeport-McMoRan, Southern Copper

Thursday: LVMH, STMicroelectronics, Sartorius, SAP, Deutsche Bank, Unicredit, Diageo, Apple, Visa, Mastercard, McDonald’s

Friday: Volvo, H&M, Givaudan , Chevron, Caterpillar, Colgate-Palmolive


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.